Global neuro-oncology: what lies ahead for low- and middle-income countries?
Recommended Citation
Enam SA, Park KB, Mushtaq N, Raghib MF, Mustansir F, Shah MM, Bajwa MH, Faisal M, Dewan MC, Khan T, and Rock JP. Global neuro-oncology: what lies ahead for low- and middle-income countries? J Pak Med Assoc 2024; 74(3 (Supple-3)):S16-s23.
Document Type
Article
Publication Date
3-1-2024
Publication Title
JPMA. The Journal of the Pakistan Medical Association
Abstract
Over the past few decades, the global healthcare community has achieved remarkable success in controlling many communicable diseases across various regions. However, non-communicable diseases now constitute a significant portion of disease morbidity and mortality, particularly in low- and middle-income countries (LMICs). Among these, cancer, in particular, is witnessing a notable increase in incidence in many LMICs. Among cancers, neurological tumours bear significant impact in terms of long-term disability, escalating costs of comprehensive multidisciplinary care, and often encounter resource-related and systemic delays in care leading to worse outcomes. This opinion paper discusses key concepts in developing global neuro-oncology care, with specific case examples from Pakistan to illustrate methods for improving care in these underserved regions. Additionally, it outlines strategic approaches and potential solutions to address these challenges, aiming to provide a roadmap for enhancing neuro-oncology care in LMICs.
Medical Subject Headings
Humans; Developing Countries; Pakistan; Medical Oncology; Global Health; Brain Neoplasms; Nervous System Neoplasms; Neurology
PubMed ID
39262062
Volume
74
Issue
3 (Supple-3)
First Page
S16
Last Page
S23
